{"id":135156,"date":"2023-08-24T12:05:09","date_gmt":"2023-08-24T06:35:09","guid":{"rendered":"https:\/\/www.oliveboard.in\/blog\/?p=135156"},"modified":"2023-08-24T12:05:10","modified_gmt":"2023-08-24T06:35:10","slug":"fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health","status":"publish","type":"post","link":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/","title":{"rendered":"FDA Approves Pfizer&#8217;s Maternal RSV Vaccine for Infant Health"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_77 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#Revolutionizing_Infant_Protection\" >Revolutionizing Infant Protection<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#Empowering_Maternal_and_Infant_Wellness_Pfizers_Maternal_RSV_Vaccine\" >Empowering Maternal and Infant Wellness: Pfizer&#8217;s Maternal RSV Vaccine<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#Confronting_RSV-Linked_Challenges_Pfizers_Maternal_RSV_Vaccine\" >Confronting RSV-Linked Challenges: Pfizer&#8217;s Maternal RSV Vaccine<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#Navigating_Seasonal_Hurdles_and_Long-Term_Impacts\" >Navigating Seasonal Hurdles and Long-Term Impacts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#Extended_Protection_for_a_Promising_Future\" >Extended Protection for a Promising Future<\/a><\/li><\/ul><\/nav><\/div>\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Revolutionizing_Infant_Protection\"><\/span>Revolutionizing Infant Protection<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The U.S. Food and Drug Administration (FDA) has given the green light to Pfizer&#8217;s pioneering maternal RSV vaccine, a groundbreaking shield against Respiratory Syncytial Virus (RSV)-associated Lower Respiratory Tract Disease (LRTD). This approval carries immense significance, particularly for infants aged birth to six months, who are vulnerable to severe RSV-related illnesses.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Empowering_Maternal_and_Infant_Wellness_Pfizers_Maternal_RSV_Vaccine\"><\/span>Empowering Maternal and Infant Wellness: Pfizer&#8217;s Maternal RSV Vaccine<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>An Evolution in Healthcare<\/strong><\/p>\n\n\n\n<p>Pfizer&#8217;s maternal respiratory syncytial vaccine, branded as Abrysvo, lies at the core of this FDA endorsement. Designed for pregnant individuals, it is administered between the 32nd and 36th week of gestation through a single-dose injection. This innovative approach holds the potential to drastically reduce the occurrence and gravity of RSV-related illnesses among infants.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Confronting_RSV-Linked_Challenges_Pfizers_Maternal_RSV_Vaccine\"><\/span>Confronting RSV-Linked Challenges: Pfizer&#8217;s Maternal RSV Vaccine<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Leading the Fight against RSV<\/strong><\/p>\n\n\n\n<p>Respiratory Syncytial Virus (RSV) is a predominant cause of Lower Respiratory Tract Disease (LRTD) in infants. The first three months of life are particularly precarious, with RSV often leading to bronchiolitis and pneumonia. By permitting the vaccine&#8217;s use during pregnancy, healthcare providers aim to curb RSV-related ailments, ultimately easing the burden on families and healthcare systems.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Navigating_Seasonal_Hurdles_and_Long-Term_Impacts\"><\/span>Navigating Seasonal Hurdles and Long-Term Impacts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>RSV in Focus<\/strong><\/p>\n\n\n\n<p>RSV follows a seasonal trajectory in the United States, peaking during winter. Although common, RSV infections can have severe consequences, particularly in infants within their first year, contributing to high infant hospitalization rates.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Extended_Protection_for_a_Promising_Future\"><\/span>Extended Protection for a Promising Future<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Uplifting Infant Health Safeguards<\/strong><\/p>\n\n\n\n<p>By encompassing pregnant individuals and their infants, Pfizer&#8217;s vaccine holds the potential to significantly diminish the impact of RSV-related illnesses on families and healthcare systems. With medical science advancing, this achievement marks the dawn of a healthier future for society&#8217;s most vulnerable members. The FDA&#8217;s approval of Pfizer&#8217;s maternal RSV vaccine sets the stage for a transformative era in infant healthcare.<\/p>\n\n\n<ul class=\"wp-block-latest-posts__list wp-block-latest-posts\"><li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.oliveboard.in\/blog\/rbi-assistant-call-letter\/\">RBI Assistant Admit Card 2026 Out for Manipur Region<\/a><\/li>\n<li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.oliveboard.in\/blog\/union-bank-apprentice-salary\/\">Union Bank Apprentice Salary 2026, Stipend and Job Profile Details<\/a><\/li>\n<li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.oliveboard.in\/blog\/union-bank-of-india-apprentice-syllabus\/\">Union Bank Apprentice Syllabus 2026 &amp; Exam Pattern<\/a><\/li>\n<li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.oliveboard.in\/blog\/union-bank-of-india-apprentice-recruitment\/\">Union Bank Apprentice Recruitment 2026, Apply 1865 Posts<\/a><\/li>\n<li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.oliveboard.in\/blog\/types-of-money-and-cheques-notes\/\">Types of Money &amp; Cheques Notes, PDF &amp; Quiz for Exams<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Revolutionizing Infant Protection The U.S. Food and Drug Administration (FDA) has given the green light to Pfizer&#8217;s pioneering maternal RSV<\/p>\n","protected":false},"author":52,"featured_media":135173,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12574,10386],"tags":[77],"class_list":["post-135156","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-august","category-current-affairs","tag-current-affairs","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA Approves Pfizer&#039;s Maternal RSV Vaccine for Infant Health<\/title>\n<meta name=\"description\" content=\"FDA approves Pfizer&#039;s Maternal RSV Vaccine, shielding infants from severe RSV-linked illnesses, vital for newborns.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Approves Pfizer&#039;s Maternal RSV Vaccine for Infant Health\" \/>\n<meta property=\"og:description\" content=\"Revolutionizing Infant Protection The U.S. Food and Drug Administration (FDA) has given the green light to Pfizer&#039;s pioneering maternal RSV vaccine, a\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Oliveboard\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Oliveboard\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-24T06:35:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-24T06:35:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Priti Palit\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Oliveboard\" \/>\n<meta name=\"twitter:site\" content=\"@Oliveboard\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Priti Palit\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/\"},\"author\":{\"name\":\"Priti Palit\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#\/schema\/person\/c7ea833786c4ccbdc498476ffc64bb35\"},\"headline\":\"FDA Approves Pfizer&#8217;s Maternal RSV Vaccine for Infant Health\",\"datePublished\":\"2023-08-24T06:35:09+00:00\",\"dateModified\":\"2023-08-24T06:35:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/\"},\"wordCount\":322,\"publisher\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png\",\"keywords\":[\"Current Affairs\"],\"articleSection\":[\"August\",\"Current Affairs\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/\",\"url\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/\",\"name\":\"FDA Approves Pfizer's Maternal RSV Vaccine for Infant Health\",\"isPartOf\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png\",\"datePublished\":\"2023-08-24T06:35:09+00:00\",\"dateModified\":\"2023-08-24T06:35:10+00:00\",\"description\":\"FDA approves Pfizer's Maternal RSV Vaccine, shielding infants from severe RSV-linked illnesses, vital for newborns.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#primaryimage\",\"url\":\"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png\",\"contentUrl\":\"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.oliveboard.in\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prep Resources\",\"item\":\"https:\/\/www.oliveboard.in\/blog\/category\/preparation-resources\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Current Affairs\",\"item\":\"https:\/\/www.oliveboard.in\/blog\/category\/preparation-resources\/current-affairs\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"FDA Approves Pfizer&#8217;s Maternal RSV Vaccine for Infant Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#website\",\"url\":\"https:\/\/www.oliveboard.in\/blog\/\",\"name\":\"Oliveboard\",\"description\":\"Free Govt. Exam Alerts &amp; Resources\",\"publisher\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oliveboard.in\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#organization\",\"name\":\"Oliveboard\",\"url\":\"https:\/\/www.oliveboard.in\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2021\/11\/logo.png\",\"contentUrl\":\"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2021\/11\/logo.png\",\"width\":150,\"height\":40,\"caption\":\"Oliveboard\"},\"image\":{\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Oliveboard\",\"https:\/\/x.com\/Oliveboard\",\"https:\/\/www.instagram.com\/oliveboard.in\/\",\"https:\/\/www.youtube.com\/channel\/UCRvrHAyNdOMI_JBkE2pjZtw?sub_confirmation=1\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#\/schema\/person\/c7ea833786c4ccbdc498476ffc64bb35\",\"name\":\"Priti Palit\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.oliveboard.in\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f163329b4fb0924a5d8232a8eab6d62977bcb9391e09b0a76b6ca8e718fab118?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f163329b4fb0924a5d8232a8eab6d62977bcb9391e09b0a76b6ca8e718fab118?s=96&d=mm&r=g\",\"caption\":\"Priti Palit\"},\"description\":\"Priti Palit, is an accomplished edtech writer with 4+ years of experience in Regulatory Exams and other multiple government exams. With a passion for education and a keen eye for detail, she has contributed significantly to the field of online learning. Priti's expertise and dedication continue to empower aspiring individuals in their pursuit of success in government examinations.\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA Approves Pfizer's Maternal RSV Vaccine for Infant Health","description":"FDA approves Pfizer's Maternal RSV Vaccine, shielding infants from severe RSV-linked illnesses, vital for newborns.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/","og_locale":"en_US","og_type":"article","og_title":"FDA Approves Pfizer's Maternal RSV Vaccine for Infant Health","og_description":"Revolutionizing Infant Protection The U.S. Food and Drug Administration (FDA) has given the green light to Pfizer's pioneering maternal RSV vaccine, a","og_url":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/","og_site_name":"Oliveboard","article_publisher":"https:\/\/www.facebook.com\/Oliveboard","article_published_time":"2023-08-24T06:35:09+00:00","article_modified_time":"2023-08-24T06:35:10+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png","type":"image\/png"}],"author":"Priti Palit","twitter_card":"summary_large_image","twitter_creator":"@Oliveboard","twitter_site":"@Oliveboard","twitter_misc":{"Written by":"Priti Palit","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#article","isPartOf":{"@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/"},"author":{"name":"Priti Palit","@id":"https:\/\/www.oliveboard.in\/blog\/#\/schema\/person\/c7ea833786c4ccbdc498476ffc64bb35"},"headline":"FDA Approves Pfizer&#8217;s Maternal RSV Vaccine for Infant Health","datePublished":"2023-08-24T06:35:09+00:00","dateModified":"2023-08-24T06:35:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/"},"wordCount":322,"publisher":{"@id":"https:\/\/www.oliveboard.in\/blog\/#organization"},"image":{"@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png","keywords":["Current Affairs"],"articleSection":["August","Current Affairs"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/","url":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/","name":"FDA Approves Pfizer's Maternal RSV Vaccine for Infant Health","isPartOf":{"@id":"https:\/\/www.oliveboard.in\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#primaryimage"},"image":{"@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png","datePublished":"2023-08-24T06:35:09+00:00","dateModified":"2023-08-24T06:35:10+00:00","description":"FDA approves Pfizer's Maternal RSV Vaccine, shielding infants from severe RSV-linked illnesses, vital for newborns.","breadcrumb":{"@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#primaryimage","url":"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png","contentUrl":"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2023\/08\/Pfizers-Maternal-RSV-Vaccine-1.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.oliveboard.in\/blog\/fda-approves-pfizers-maternal-rsv-vaccine-for-infant-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oliveboard.in\/blog\/"},{"@type":"ListItem","position":2,"name":"Prep Resources","item":"https:\/\/www.oliveboard.in\/blog\/category\/preparation-resources\/"},{"@type":"ListItem","position":3,"name":"Current Affairs","item":"https:\/\/www.oliveboard.in\/blog\/category\/preparation-resources\/current-affairs\/"},{"@type":"ListItem","position":4,"name":"FDA Approves Pfizer&#8217;s Maternal RSV Vaccine for Infant Health"}]},{"@type":"WebSite","@id":"https:\/\/www.oliveboard.in\/blog\/#website","url":"https:\/\/www.oliveboard.in\/blog\/","name":"Oliveboard","description":"Free Govt. Exam Alerts &amp; Resources","publisher":{"@id":"https:\/\/www.oliveboard.in\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oliveboard.in\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.oliveboard.in\/blog\/#organization","name":"Oliveboard","url":"https:\/\/www.oliveboard.in\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oliveboard.in\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2021\/11\/logo.png","contentUrl":"https:\/\/www.oliveboard.in\/blog\/wp-content\/uploads\/2021\/11\/logo.png","width":150,"height":40,"caption":"Oliveboard"},"image":{"@id":"https:\/\/www.oliveboard.in\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Oliveboard","https:\/\/x.com\/Oliveboard","https:\/\/www.instagram.com\/oliveboard.in\/","https:\/\/www.youtube.com\/channel\/UCRvrHAyNdOMI_JBkE2pjZtw?sub_confirmation=1"]},{"@type":"Person","@id":"https:\/\/www.oliveboard.in\/blog\/#\/schema\/person\/c7ea833786c4ccbdc498476ffc64bb35","name":"Priti Palit","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oliveboard.in\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f163329b4fb0924a5d8232a8eab6d62977bcb9391e09b0a76b6ca8e718fab118?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f163329b4fb0924a5d8232a8eab6d62977bcb9391e09b0a76b6ca8e718fab118?s=96&d=mm&r=g","caption":"Priti Palit"},"description":"Priti Palit, is an accomplished edtech writer with 4+ years of experience in Regulatory Exams and other multiple government exams. With a passion for education and a keen eye for detail, she has contributed significantly to the field of online learning. Priti's expertise and dedication continue to empower aspiring individuals in their pursuit of success in government examinations."}]}},"_links":{"self":[{"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/posts\/135156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/users\/52"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/comments?post=135156"}],"version-history":[{"count":3,"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/posts\/135156\/revisions"}],"predecessor-version":[{"id":135174,"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/posts\/135156\/revisions\/135174"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/media\/135173"}],"wp:attachment":[{"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/media?parent=135156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/categories?post=135156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oliveboard.in\/blog\/wp-json\/wp\/v2\/tags?post=135156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}